Literature DB >> 20663542

Feasibility of less radical surgery for superficially invasive carcinoma of the cervix.

Mi-Kyung Kim1, Jae Weon Kim, Min A Kim, Hee Seung Kim, Hyun Hoon Chung, Noh-Hyun Park, In Ae Park, Yong-Sang Song, Soon-Beom Kang.   

Abstract

OBJECTIVE: To determine the incidence of parametrial involvement in patients with superficially invasive cervical cancer and to assess the feasibility of less radical surgery in this subset of patients. PATIENTS AND METHODS: A retrospective analysis was performed in 375 patients with stage IB1 cervical cancer who underwent radical surgery at Seoul National University Hospital from 2000 to 2008. Parametrial involvement in patients with invasion ≤5 mm was the primary outcome of this study. In addition, the differences in pathologic variables according to the depth of invasion (≤5 vs. >5 mm) were evaluated using chi-square test or Fisher's exact test. Survivals were also estimated using Kaplan-Meier method and log-rank test.
RESULTS: During the study period, 140 cases with invasion ≤5 mm were identified. Mean depth of invasion was 3.30±1.36 mm, and mean diameter of width was 16.6±7.5 mm (range, 2-36 mm). None of these patients had parametrial involvement. However, lymph node metastasis was present in 5 patients (3.6%). In contrast, among patients with invasion >5 mm, parametrial invasion and lymph node metastasis were present in 36 (15.3%) and 54 patients (23.0%), respectively. 5-year disease-free survival in patients with invasion≤5 mm was 97.5%, which was significantly better than 87.3% in patients with invasion>5 mm (P=0.002).
CONCLUSION: We have demonstrated that stage IB1 patients with depth of invasion≤5 mm are at very low risk for parametrial involvement. These low-risk patients could be candidates for prospective clinical trials on less radical surgery omitting parametrectomy.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20663542     DOI: 10.1016/j.ygyno.2010.06.027

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

1.  Surgical management of early cervical cancer: the shape of future studies.

Authors:  Stefano Greggi; Cono Scaffa
Journal:  Curr Oncol Rep       Date:  2012-12       Impact factor: 5.075

Review 2.  Fertility-Sparing Options in Young Women with Cervical Cancer.

Authors:  Federica Tomao; Giacomo Corrado; Fedro Alessandro Peccatori; Sara Boveri; Eleonora Petra Preti; Nicoletta Colombo; Fabio Landoni
Journal:  Curr Treat Options Oncol       Date:  2016-01

Review 3.  Barriers and Challenges to Treatment Alternatives for Early-Stage Cervical Cancer in Lower-Resource Settings.

Authors:  Emily S Wu; Jose Jeronimo; Sarah Feldman
Journal:  J Glob Oncol       Date:  2017-05-11

4.  The Relationship Between Parametrial Involvement and Parametrial Tissue Removed in Radical Surgery in Early-Stage Cervical Cancer.

Authors:  Ozer Birge; Mehmet Sait Bakir; Selen Dogan; Hasan Aykut Tuncer; Tayup Simsek
Journal:  World J Oncol       Date:  2022-04-23

Review 5.  Surgery for cervical cancer: consensus & controversies.

Authors:  Pabashi Poddar; Amita Maheshwari
Journal:  Indian J Med Res       Date:  2021-08       Impact factor: 5.274

6.  Can radical parametrectomy be omitted in occult cervical cancer after extrafascial hysterectomy?

Authors:  Huai-Wu Lu; Jing Li; Yun-Yun Liu; Chang-Hao Liu; Guo-Cai Xu; Ling-Ling Xie; Miao-Fang Wu; Zhong-Qiu Lin
Journal:  Chin J Cancer       Date:  2015-08-08

7.  Accuracy of conization procedure for predicting pathological parameters of radical hysterectomy in stage Ia2-Ib1 (≤2 cm) cervical cancer.

Authors:  Huimin Bai; Dongyan Cao; Fang Yuan; Huilan Wang; Meizhu Xiao; Jie Chen; Quancai Cui; Keng Shen; Zhenyu Zhang
Journal:  Sci Rep       Date:  2016-05-16       Impact factor: 4.379

8.  Factors associated with parametrial involvement in patients with stage IB1 cervical cancer: Who is suitable for less radical surgery?

Authors:  Seung-Ho Lee; Kyoung-Joo Cho; Mi-Hyang Ko; Hyun-Yee Cho; Kwang-Beom Lee; Soyi Lim
Journal:  Obstet Gynecol Sci       Date:  2017-12-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.